Table 5 Therapeutic modalities in 2012 (n = 104)
| Pharmacological prophylaxis | women and men | women | men |
|---|---|---|---|
| tranexamic acid | 10 | 6 (10 %) | 4 (8 %) |
| danazol | 26 | 13 (23 %) | 13 (27 % |
| IRT | |||
| pd C1 - INH | 9 | 7 (12 %) | 2 (4 %) |
| Therapy of acute attacks | |||
| Icatibant | 12 | 9 (16 %) | 3 (6 %) |
| pd C1 – INH | 57 | 32 (56 %) | 25 (53 %) |